한글목차

소외열대질환 진단(NTDs)의 동향과 예측

세계의 소외열대질환 진단 시장은 2024-2030년 CAGR 4.9%로 성장할 것으로 예측됩니다. 이 시장의 주요 촉진요인은 간과되고 있는 열대병이 증가하고 있는 것, 신속 진단 검사에 대한 수요가 높아지고 있는 것, 그리고 NTDs에 대한 인식이 높아지고 있는 것입니다. 세계의 소외열대질환 진단 시장의 미래는 병원·클리닉, 홈헬스케어, 임상 검사 시장에서 유망합니다.

소외열대질환 진단 시장 인사이트

Lucintel은 선진국에서 뎅기 바이러스 검출을 위한 POC(Point of Care) 검사의 채택 증가에 의해 뎅기열이 예측 기간 중 최대 부문을 유지할 것으로 예측하고 있습니다.

이 시장에서 임상 검사실은 전 세계에서 검사실 수의 증가와 임상 검사실에서 첨단 기기의 이용 가능성 증가에 의해 최대 부문을 유지할 것으로 생각됩니다.

북미는 숙련된 헬스케어 전문가의 존재와 이 지역에서 재택의료에서의 POC(Point of Care) 검사 서비스의 채택 증가에 의해 예측 기간 중에도 최대 부문을 유지할 것으로 생각됩니다.

자주 묻는 질문

Q1.시장의 성장 예측은?

A1.세계의 소외열대질환 진단 시장은 2024-2030년 CAGR 4.9%로 성장할 것으로 예측되고 있습니다.

Q2.시장의 성장에 영향을 미치는 주요 촉진요인은?

A2.이 시장의 주요 촉진요인은 간과되고 있는 열대병 수의 증가, 신속 진단 검사에 대한 수요의 증가, 그리고 소외열대질환에 대한 인식의 향상입니다.

Q3.시장의 주요 부문은?

A3.소외열대질환 진단 시장의 미래는 병원·클리닉, 홈헬스케어, 임상 검사 시장에서 유망합니다.

Q4.시장의 주요 기업은?

A4.소외열대질환 진단의 주요 기업은 다음과 같습니다.

• F. Hoffmann-La Roche
• Thermo Fisher Scientific
• InBios International
• Omega Diagnostics
• Oscar Medicare
• EUROIMMUN
• Novartis
• Grifols
• ZeptoMetrix
• DiaSys Diagnostic Systems

Q5.향후 최대가 되는 시장 부문은?

A5.Lucintel은 선진국에서 뎅기 바이러스 검출을 위한 POC(Point of Care) 검사의 채택 증가에 의해 뎅기열이 예측 기간 중 최대 부문을 유지할 것으로 예측하고 있습니다.

Q6.시장에서 향후 5년간 최대가 될 것으로 예상되는 지역은?

A6.북미는 숙련된 헬스케어 전문가가 존재하고, 재택의료에서 POC(Point of Care) 검사 서비스의 채택이 증가하고 있으므로 예측 기간 중에도 최대 부문을 유지할 것입니다.

Q7.리포트의 커스터마이즈는 가능?

A7.네, Lucintel은 추가 비용 없이 10%의 커스터마이즈를 제공합니다.

목차

제1장 주요 요약

제2장 세계의 소외열대질환 진단 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계의 촉진요인과 과제

제3장 2018-2030년의 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 소외열대질환 진단 시장 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 소외열대질환 진단 시장 : 질환의 유형별
  • 뎅기열
  • 치쿤구니야 열
  • 광견병
  • 림프사상충증
  • 부룰리 궤양
  • 식중독흡충증
  • 포충증
  • 한센병
  • 기타
• 세계의 소외열대질환 진단 시장 : 방법별
  • 기존 방법
  • 분자법
• 세계의 소외열대질환 진단 시장 : 서비스 유형별
  • 일원화된 서비스
  • POC(Point of Care) 검사
• 세계의 소외열대질환 진단 시장 : 최종 용도별
  • 병원과 진료소
  • 홈헬스케어
  • 임상 검사실
  • 기타

제4장 2018-2030년의 지역별 시장 동향과 예측 분석

• 지역별 세계의 소외열대질환 진단 시장
• 북미의 소외열대질환 진단 시장
• 유럽의 소외열대질환 진단 시장
• 아시아태평양의 소외열대질환 진단 시장
• 기타 지역의 소외열대질환 진단 시장

제5장 경쟁의 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 질환의 유형별
  • 방법별
  • 서비스 유형별
  • 최종 용도별
  • 지역별
• 세계의 소외열대질환 진단 시장에서 새로운 동향
• 전략적 분석
  • 신제품의 개발
  • 세계의 소외열대질환 진단 시장의 능력 확대
  • 세계의 소외열대질환 진단 시장에서의 합병, 인수, 합병사업
  • 인증과 라이선싱

제7장 유력 기업의 기업 개요

• F. Hoffmann-La Roche
• Thermo Fisher Scientific
• InBios International
• Omega Diagnostics
• Oscar Medicare
• EUROIMMUN
• Novartis
• Grifols
• ZeptoMetrix
• DiaSys Diagnostic Systems

영문목차

Neglected Tropical Disease Diagnosis Trends and Forecast

The future of the global neglected tropical disease diagnosis market looks promising with opportunities in the hospital and clinic, home healthcare, and clinical laboratory markets. The global neglected tropical disease diagnosis market is expected to grow with a CAGR of 4.9% from 2024 to 2030. The major drivers for this market are escalating number of overlooked tropical diseases, rising demand for rapid diagnostic tests, and mounting recognition of NTDs.

A more than 150-page report is developed to help in your business decisions.

Neglected Tropical Disease Diagnosis by Segment

The study includes a forecast for the global neglected tropical disease diagnosis by disease type, method, service type, end use, and region.

Neglected Tropical Disease Diagnosis Market by Disease Type [Shipment Analysis by Value from 2018 to 2030]:

• Dengue
• Chikungunya
• Rabies
• Lymphatic Filariasis
• Buruli Ulcer
• Foodborne Trematodiases
• Echinococcosis
• Leprosy
• Others

Neglected Tropical Disease Diagnosis Market by Method [Shipment Analysis by Value from 2018 to 2030]:

• Conventional Method
• Molecular Method

Neglected Tropical Disease Diagnosis Market by Service Type [Shipment Analysis by Value from 2018 to 2030]:

• Centralized Service
• Point-of-Care Testing

Neglected Tropical Disease Diagnosis Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospital and Clinic
• Home Healthcare
• Clinical Laboratories
• Others

Neglected Tropical Disease Diagnosis Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Neglected Tropical Disease Diagnosis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies neglected tropical disease diagnosis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the neglected tropical disease diagnosis companies profiled in this report include-

• F. Hoffmann-La Roche
• Thermo Fisher Scientific
• InBios International
• Omega Diagnostics
• Oscar Medicare
• EUROIMMUN
• Novartis
• Grifols
• ZeptoMetrix
• DiaSys Diagnostic Systems

Neglected Tropical Disease Diagnosis Market Insights

Lucintel forecasts that dengue will remain the largest segment over the forecast period due to increasing adoption of point-of-care testing for dengue virus detection in developed nations.

Within this market, clinical laboratory will remain the largest segment due to increased number of laboratories across world and rising availability of advanced equipment in clinical laboratories.

North America will remain the largest segment over the forecast period due to existence of skilled healthcare professionals and growing adoption of point-of-care testing services at home healthcare in the region.

Features of the Global Neglected Tropical Disease Diagnosis Market

Market Size Estimates: Neglected tropical disease diagnosis market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Neglected tropical disease diagnosis market size by various segments, such as by disease type, method, service type, end use, and region in terms of value ($B).

Regional Analysis: Neglected tropical disease diagnosis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different disease types, methods, service types, end uses, and regions for the neglected tropical disease diagnosis market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the neglected tropical disease diagnosis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for neglected tropical disease diagnosis market?

Answer: The global neglected tropical disease diagnosis market is expected to grow with a CAGR of 4.9% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the neglected tropical disease diagnosis market?

Answer: The major drivers for this market are escalating number of overlooked tropical diseases, rising demand for rapid diagnostic tests and mounting recognition of ntds.

Q3. What are the major segments for neglected tropical disease diagnosis market?

Answer: The future of the neglected tropical disease diagnosis market looks promising with opportunities in the hospital and clinic, home healthcare, and clinical laboratory markets.

Q4. Who are the key neglected tropical disease diagnosis market companies?

Answer: Some of the key neglected tropical disease diagnosis companies are as follows.

• F. Hoffmann-La Roche
• Thermo Fisher Scientific
• InBios International
• Omega Diagnostics
• Oscar Medicare
• EUROIMMUN
• Novartis
• Grifols
• ZeptoMetrix
• DiaSys Diagnostic Systems

Q5. Which neglected tropical disease diagnosis market segment will be the largest in future?

Answer: Lucintel forecasts that dengue will remain the largest segment over the forecast period due to increasing adoption of point-of-care testing for dengue virus detection in developed nations.

Q6. In neglected tropical disease diagnosis market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest segment over the forecast period due to existence of skilled healthcare professionals and growing adoption of point-of-care testing services at home healthcare in the region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the neglected tropical disease diagnosis market by disease type (dengue, chikungunya, rabies, lymphatic filariasis, buruli ulcer, foodborne trematodiases, echinococcosis, leprosy, and others), method (conventional method and molecular method), service type (centralized service and point-of-care testing), end use (hospital and clinic, home healthcare, clinical laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Neglected Tropical Disease Diagnosis Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Neglected Tropical Disease Diagnosis Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Neglected Tropical Disease Diagnosis Market by Disease Type
  • 3.3.1: Dengue
  • 3.3.2: Chikungunya
  • 3.3.3: Rabies
  • 3.3.4: Lymphatic Filariasis
  • 3.3.5: Buruli Ulcer
  • 3.3.6: Foodborne Trematodiases
  • 3.3.7: Echinococcosis
  • 3.3.8: Leprosy
  • 3.3.9: Others
• 3.4: Global Neglected Tropical Disease Diagnosis Market by Method
  • 3.4.1: Conventional Method
  • 3.4.2: Molecular Method
• 3.5: Global Neglected Tropical Disease Diagnosis Market by Service Type
  • 3.5.1: Centralized Service
  • 3.5.2: Point-of-Care Testing
• 3.6: Global Neglected Tropical Disease Diagnosis Market by End Use
  • 3.6.1: Hospital and Clinic
  • 3.6.2: Home Healthcare
  • 3.6.3: Clinical Laboratories
  • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Neglected Tropical Disease Diagnosis Market by Region
• 4.2: North American Neglected Tropical Disease Diagnosis Market
  • 4.2.2: North American Neglected Tropical Disease Diagnosis Market by End Use: Hospital and Clinic, Home Healthcare, Clinical Laboratories, and Others
• 4.3: European Neglected Tropical Disease Diagnosis Market
  • 4.3.1: European Neglected Tropical Disease Diagnosis Market by Disease Type: Dengue, Chikungunya, Rabies, Lymphatic Filariasis, Buruli Ulcer, Foodborne Trematodiases, Echinococcosis, Leprosy, and Others
  • 4.3.2: European Neglected Tropical Disease Diagnosis Market by End Use: Hospital and Clinic, Home Healthcare, Clinical Laboratories, and Others
• 4.4: APAC Neglected Tropical Disease Diagnosis Market
  • 4.4.1: APAC Neglected Tropical Disease Diagnosis Market by Disease Type: Dengue, Chikungunya, Rabies, Lymphatic Filariasis, Buruli Ulcer, Foodborne Trematodiases, Echinococcosis, Leprosy, and Others
  • 4.4.2: APAC Neglected Tropical Disease Diagnosis Market by End Use: Hospital and Clinic, Home Healthcare, Clinical Laboratories, and Others
• 4.5: ROW Neglected Tropical Disease Diagnosis Market
  • 4.5.1: ROW Neglected Tropical Disease Diagnosis Market by Disease Type: Dengue, Chikungunya, Rabies, Lymphatic Filariasis, Buruli Ulcer, Foodborne Trematodiases, Echinococcosis, Leprosy, and Others
  • 4.5.2: ROW Neglected Tropical Disease Diagnosis Market by End Use: Hospital and Clinic, Home Healthcare, Clinical Laboratories, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Neglected Tropical Disease Diagnosis Market by Disease Type
  • 6.1.2: Growth Opportunities for the Global Neglected Tropical Disease Diagnosis Market by Method
  • 6.1.3: Growth Opportunities for the Global Neglected Tropical Disease Diagnosis Market by Service Type
  • 6.1.4: Growth Opportunities for the Global Neglected Tropical Disease Diagnosis Market by End Use
  • 6.1.5: Growth Opportunities for the Global Neglected Tropical Disease Diagnosis Market by Region
• 6.2: Emerging Trends in the Global Neglected Tropical Disease Diagnosis Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Neglected Tropical Disease Diagnosis Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Neglected Tropical Disease Diagnosis Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: F. Hoffmann-La Roche
• 7.2: Thermo Fisher Scientific
• 7.3: InBios International
• 7.4: Omega Diagnostics
• 7.5: Oscar Medicare
• 7.6: EUROIMMUN
• 7.7: Novartis
• 7.8: Grifols
• 7.9: ZeptoMetrix
• 7.10: DiaSys Diagnostic Systems